المؤلفون: Maisonobe, Lucas, Bertinchamp, Rémi, Damian, Louise, Gérard, Laurence, Berisha, Mirlinda, Guillet, Stéphanie, Fieschi, Claire, Malphettes, Marion, Fadlallah, Jehane, Hié, Miguel, Dunogué, Bertrand, De Wilde, Virginie, Vandergheynst, Frederic, Zafrani, Lara, Grall, Maximilien, Saada, Noémie, Garzaro, Margaux, Oksenhendler, Eric, Galicier, Lionel, Boutboul, David

المصدر: British journal of haematology, 196 (3

مصطلحات موضوعية: Sciences bio-médicales et agricoles, Adult, Biopsy, Castleman Disease -- diagnosis -- etiology -- mortality -- therapy, Clinical Decision-Making, Combined Modality Therapy, Diagnosis, Differential, Disease Management, Disease Susceptibility, Female, Humans, Immunohistochemistry, Male, Middle Aged, Phenotype, Positron Emission Tomography Computed Tomography, Prognosis, Retrospective Studies, Syndrome, Treatment Outcome, Young Adult, Western thrombocytopenia, anasarca, fever, idiopathic multicentric Castleman disease, reticulin fibrosis and organomegaly syndrome, rituximab, tocilizumab

وصف الملف: 3 full-text file(s): application/pdf | application/pdf | application/pdf

العلاقة: uri/info:doi/10.1111/bjh.17868; uri/info:pmid/34585382; uri/info:scp/85115871608; https://dipot.ulb.ac.be/dspace/bitstream/2013/355095/5/Article.pdfTest; https://dipot.ulb.ac.be/dspace/bitstream/2013/355095/1/.pdfTest; https://dipot.ulb.ac.be/dspace/bitstream/2013/355095/6/Article.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/355095Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/355095Test
https://dipot.ulb.ac.be/dspace/bitstream/2013/355095/5/Article.pdfTest
https://dipot.ulb.ac.be/dspace/bitstream/2013/355095/1/.pdfTest
https://dipot.ulb.ac.be/dspace/bitstream/2013/355095/6/Article.pdfTest

المؤلفون: Sculier, Jean-Paul, Berghmans, Thierry, Meert, Anne-Pascale

المصدر: Lung cancer, 84 (2

مصطلحات موضوعية: Médecine pathologie humaine, Biologie, Combined Modality Therapy, Disease Management, Humans, Lung Neoplasms -- mortality -- therapy, Retrospective Studies, Small Cell Lung Carcinoma -- mortality -- therapy

وصف الملف: 2 full-text file(s): application/pdf | application/pdf

العلاقة: uri/info:doi/10.1016/S0169-5002(14)00175-5; uri/info:pii/S0169-5002(14)00175-5; uri/info:pmid/24767173; uri/info:scp/84899140646; https://dipot.ulb.ac.be/dspace/bitstream/2013/163509/1/2014LUNGCANCERSCULIER.pdfTest; https://dipot.ulb.ac.be/dspace/bitstream/2013/163509/3/Elsevier_147139.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/163509Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/163509Test
https://dipot.ulb.ac.be/dspace/bitstream/2013/163509/1/2014LUNGCANCERSCULIER.pdfTest
https://dipot.ulb.ac.be/dspace/bitstream/2013/163509/3/Elsevier_147139.pdfTest

المؤلفون: Poddighe, Pino J, Weghuis, Daniel Olde

المساهمون: Department of Clinical Genetics, VU University Medical Center, Amsterdam (PJP) The Netherlands, Department of Human Genetics, Radboud University Nijmegen Medical Centre (DOW), The Netherlands

مصطلحات موضوعية: chromosome 15, chromosome 17, PML, RARA, acute promyelocytic leukaemia, Leukaemia Section, Antineoplastic Agents/*therapeutic use/toxicity, Clinical Trials as Topic, Humans, Leukemia, Promyelocytic, Acute/*drug therapy, Treatment Outcome, Tretinoin/*therapeutic use/toxicity, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, Bone Marrow Transplantation, Cell Differentiation/drug effects, China, Combined Modality Therapy, Cytarabine/administration & dosage, Daunorubicin/administration & dosage, Disease-Free Survival, Etoposide/administration & dosage, Europe, Immunologic Factors/adverse effects/*therapeutic use, Acute/drug therapy/mortality/*therapy

العلاقة: Atlas of Genetics and Cytogenetics in Oncology and Haematology; http://AtlasGeneticsOncology.org/Anomalies/t1517ID1035.htmlTest; Pino J, Poddighe; Daniel Olde, Weghuis. t(15;17)(q24;q21) PML/RARA. Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2016, 12, p. 620-624; http://hdl.handle.net/2042/66951Test; https://doi.org/10.4267/2042/66951Test

الإتاحة: https://doi.org/10.4267/2042/66951Test
http://hdl.handle.net/2042/66951Test

المؤلفون: Grönbaek, H

المصدر: Ugeskrift for Laeger. 168(12):1219

المؤلفون: Daugaard, K G, Von Der, M a

المصدر: Ugeskrift for Laeger. 164(23):3063

المؤلفون: Clementsen, P, Krasnik, M, Östelind, K E

المصدر: Ugeskrift for Laeger. 164(23):3027

المؤلفون: Sham, JST, Kwok, KF, Wong, KH, Demeester, TR, Pellegrini, CA, Krupski, WC, Kwong, DLW, Law, S, Wong, J, Chu, KM

مصطلحات موضوعية: Esophagectomy, Carcinoma, Squamous Cell - mortality - therapy, Esophageal Neoplasms - mortality - therapy, Antineoplastic Agents - therapeutic use, Combined Modality Therapy

وصف الملف: 388 bytes; text/html

العلاقة: Annals of Surgery; http://www.scopus.com/mlt/select.url?eid=2-s2.0-0141871983&selection=ref&src=s&origin=recordpageTest; Annals Of Surgery, 2003, v. 238 n. 3, p. 339-348; 348; 91998; WOS:000185835200008; http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0003-4932&volume=238&issue=3&spage=339&epage=348&date=2003&atitle=Improvement+in+treatment+results+and+long-term+survival+of+patients+with+esophageal+cancer:+impact+of+chemoradiation+and+change+in+treatment+strategyTest; PMC1422701; eid_2-s2.0-0141871983; 339; http://hdl.handle.net/10722/49008Test; 238

الإتاحة: https://doi.org/10.1097/01.sla.0000086545.45918.eeTest
http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0003-4932&volume=238&issue=3&spage=339&epage=348&date=2003&atitle=Improvement+in+treatment+results+and+long-term+survival+of+patients+with+esophageal+cancer:+impact+of+chemoradiation+and+change+in+treatment+strategyTest
http://hdl.handle.net/10722/49008Test

المؤلفون: Charabi, S, Charabi, B W, Balle, V H, Berthelsen, A, Thomsen, J C

المصدر: Ugeskrift for Laeger. 161(19):2811

المؤلفون: Von Der Maase, H, Steven, K

المصدر: Ugeskrift for Laeger. 164(23):3052

المؤلفون: Jakobsen, A K, Engelholm, S A, Knudsen, J B

المصدر: Ugeskrift for Laeger. 164(23):3059